News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
856,564 Results
Type
Article (87137)
Company Profile (704)
Press Release (768704)
Multimedia
Podcasts (160)
Webinars (22)
Section
Business (232941)
Career Advice (4136)
Deals (39774)
Drug Delivery (132)
Drug Development (91168)
Employer Resources (200)
FDA (18232)
Job Trends (17382)
News (397104)
Policy (39874)
Tag
Academia (3002)
Academic (2)
Accelerated approval (16)
Adcomms (33)
Allergies (111)
Alliances (56978)
ALS (129)
Alzheimer's disease (1630)
Antibody-drug conjugate (ADC) (197)
Approvals (18214)
Artificial intelligence (436)
Autoimmune disease (39)
Automation (22)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (143)
Biotechnology (482)
Bladder cancer (110)
Brain cancer (45)
Breast cancer (424)
Cancer (3382)
Cardiovascular disease (273)
Career advice (3548)
Career pathing (34)
CAR-T (223)
CDC (43)
Cell therapy (613)
Cervical cancer (27)
Clinical research (74715)
Collaboration (1217)
Company closure (4)
Compensation (807)
Complete response letters (44)
COVID-19 (2929)
CRISPR (72)
C-suite (447)
Cystic fibrosis (128)
Data (3459)
Decentralized trials (2)
Denatured (57)
Depression (89)
Diabetes (397)
Diagnostics (7025)
Digital health (27)
Diversity (10)
Diversity, equity & inclusion (49)
Drug discovery (202)
Drug pricing (168)
Drug shortages (36)
Duchenne muscular dystrophy (174)
Earnings (98590)
Editorial (51)
Employer branding (25)
Employer resources (169)
Events (132005)
Executive appointments (940)
FDA (20365)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (11)
Funding (1087)
Gene editing (155)
Generative AI (43)
Gene therapy (482)
GLP-1 (976)
Government (5328)
Grass and pollen (7)
Guidances (328)
Healthcare (20931)
HIV (47)
Huntington's disease (32)
IgA nephropathy (50)
Immunology and inflammation (201)
Immuno-oncology (17)
Indications (44)
Infectious disease (3139)
Inflammatory bowel disease (173)
Inflation Reduction Act (13)
Influenza (83)
Intellectual property (149)
Interviews (814)
IPO (17916)
IRA (59)
Job creations (5195)
Job search strategy (2863)
Kidney cancer (15)
Labor market (66)
Layoffs (617)
Leadership (30)
Legal (10143)
Liver cancer (88)
Longevity (12)
Lung cancer (474)
Lymphoma (241)
Machine learning (17)
Management (65)
Manufacturing (522)
MASH (113)
Medical device (14794)
Medtech (14807)
Mergers & acquisitions (22649)
Metabolic disorders (1025)
Multiple sclerosis (109)
NASH (23)
Neurodegenerative disease (171)
Neuropsychiatric disorders (49)
Neuroscience (2473)
NextGen: Class of 2025 (7687)
Non-profit (5094)
Now hiring (54)
Obesity (518)
Opinion (300)
Ovarian cancer (110)
Pain (139)
Pancreatic cancer (139)
Parkinson's disease (210)
Partnered (27)
Patents (368)
Patient recruitment (231)
Peanut (55)
People (65936)
Pharmaceutical (143)
Pharmacy benefit managers (25)
Phase I (23044)
Phase II (32435)
Phase III (24428)
Pipeline (2335)
Policy (272)
Postmarket research (3554)
Preclinical (10402)
Press Release (72)
Prostate cancer (165)
Psychedelics (48)
Radiopharmaceuticals (279)
Rare diseases (579)
Real estate (7404)
Recruiting (76)
Regulatory (27534)
Reports (64)
Research institute (2668)
Resumes & cover letters (650)
Rett syndrome (11)
RNA editing (14)
RSV (62)
Schizophrenia (113)
Series A (180)
Series B (130)
Service/supplier (30)
Sickle cell disease (73)
Special edition (24)
Spinal muscular atrophy (168)
Sponsored (38)
Startups (4313)
State (2)
Stomach cancer (17)
Supply chain (89)
Tariffs (81)
The Weekly (101)
Vaccines (983)
Venture capital (63)
Weight loss (357)
Women's health (54)
Worklife (20)
Date
Today (156)
Last 7 days (536)
Last 30 days (2771)
Last 365 days (34067)
2025 (22103)
2024 (38139)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1278)
Alabama (75)
Alaska (7)
Arizona (289)
Arkansas (14)
Asia (50710)
Australia (8908)
California (8563)
Canada (2608)
China (798)
Colorado (365)
Connecticut (384)
Delaware (234)
Europe (116424)
Florida (1277)
Georgia (295)
Hawaii (3)
Idaho (67)
Illinois (775)
India (40)
Indiana (418)
Iowa (19)
Japan (255)
Kansas (120)
Kentucky (35)
Louisiana (20)
Maine (75)
Maryland (1186)
Massachusetts (6499)
Michigan (290)
Minnesota (528)
Mississippi (4)
Missouri (110)
Montana (32)
Nebraska (26)
Nevada (96)
New Hampshire (75)
New Jersey (2363)
New Mexico (31)
New York (2348)
North Carolina (1323)
North Dakota (10)
Northern California (3779)
Ohio (272)
Oklahoma (17)
Oregon (49)
Pennsylvania (1815)
Puerto Rico (18)
Rhode Island (42)
South America (1654)
South Carolina (42)
South Dakota (1)
Southern California (3224)
Tennessee (138)
Texas (1342)
United States (32002)
Utah (255)
Virginia (233)
Washington D.C. (81)
Washington State (737)
West Virginia (4)
Wisconsin (89)
There are 856,564 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Alzheimer’s
Prothena’s Alzheimer’s Drug Comes With Familiar Side Effect in Phase I Test
In another blow to Prothena’s neurodegenerative disease portfolio, anti-amyloid candidate PRX012 has run into the same problem that larger peers Biogen and Eli Lilly have battled: high rates of swelling in the brain.
August 28, 2025
·
2 min read
·
Annalee Armstrong
Interviews
Job Interviews That Needed a Do-Over
Sometimes, job interviews stand out for all the wrong reasons, including odd settings, off-topic topics and questionable decorum.
BioSpace
collected several stories that highlight biopharma professionals’ strangest experiences as they pursued employment.
August 28, 2025
·
4 min read
·
Angela Gabriel
Layoffs
Exelixis Lays Off 130 as Pennsylvania Site Closes Down
Exelixis is looking at the possibility of relocating some of the eliminated Pennsylvania roles to its headquarters in Alameda, California, according to a company spokesperson.
August 28, 2025
·
2 min read
·
Tristan Manalac
Vaccines
FDA Clears Updated COVID-19 Shots From Pfizer, Moderna, Novavax—But With Restrictions
The American Academy of Pediatrics called the decision to limit children’s access to COVID-19 vaccines “deeply troubling.”
August 28, 2025
·
2 min read
·
Tristan Manalac
Obesity
Novo Seeks RNA Approach to Obesity, Diabetes With $550M Replicate Deal
Novo Nordisk has brought on other cardiometabolic collaborators this year, including United Laboratories International and Deep Apple Therapeutics.
August 28, 2025
·
1 min read
·
Tristan Manalac
Layoff Tracker
Pfizer and Indivior Trim Workforces, Seeking Productivity Gains
Follow along as
BioSpace
tracks job cuts and restructuring initiatives throughout 2025.
August 28, 2025
·
193 min read
·
BioSpace Editorial Staff
Policy
Monarez Fired From Top CDC Spot Following Friction Over New COVID-19 Vaccine Policy
The CDC director—the first to be confirmed by the Senate under new legislation—has been ousted after less than a month following internal unrest regarding new, more restrictive approvals for updated COVID-19 vaccines, according to multiple sources.
August 28, 2025
·
3 min read
·
Heather McKenzie
Now Hiring
8 Companies Hiring in San Francisco
Looking for a biopharma job in San Francisco or South San Francisco? Check out the
BioSpace
list of eight companies hiring life sciences professionals like you.
August 28, 2025
·
1 min read
·
Chantal Dresner
Press Releases
Hua Medicine Announces 2025 Interim Results
August 28, 2025
·
11 min read
Press Releases
ProNephro AKI™ (NGAL), early detection test for Acute Kidney Injury, now commercially available to US Labs through BioPorto’s collaboration with Roche Diagnostics.
August 28, 2025
·
6 min read
1 of 85,657
Next
